These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 12687273

  • 41. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.
    Saarnio J, Parkkila S, Parkkila AK, Haukipuro K, Pastoreková S, Pastorek J, Kairaluoma MI, Karttunen TJ.
    Am J Pathol; 1998 Jul; 153(1):279-85. PubMed ID: 9665489
    [Abstract] [Full Text] [Related]

  • 42. Rapid detection of the hypoxia-regulated CA-IX and NDRG1 gene expression in different glioblastoma cells in vitro.
    Said HM, Polat B, Staab A, Hagemann C, Stein S, Flentje M, Theobald M, Katzer A, Vordermark D.
    Oncol Rep; 2008 Aug; 20(2):413-9. PubMed ID: 18636206
    [Abstract] [Full Text] [Related]

  • 43. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers.
    He F, Deng X, Wen B, Liu Y, Sun X, Xing L, Minami A, Huang Y, Chen Q, Zanzonico PB, Ling CC, Li GC.
    Cancer Res; 2008 Oct 15; 68(20):8597-606. PubMed ID: 18922936
    [Abstract] [Full Text] [Related]

  • 44. Localization and therapy of human cervical tumor xenografts with radiolabeled monoclonal antibody 1H10.
    Yu MH, Roffler SR, Hwang WS, Tung E, Chen WL, Yeh MY.
    Gynecol Oncol; 1992 Oct 15; 47(1):93-101. PubMed ID: 1427409
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
    Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E.
    Jpn J Clin Oncol; 2007 Nov 15; 37(11):812-9. PubMed ID: 18057013
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A, Dogné JM, Masereel B, Supuran CT.
    Trends Pharmacol Sci; 2006 Nov 15; 27(11):566-73. PubMed ID: 16996620
    [Abstract] [Full Text] [Related]

  • 51. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
    Muselaers CH, Stillebroer AB, Rijpkema M, Franssen GM, Oosterwijk E, Mulders PF, Oyen WJ, Boerman OC.
    J Nucl Med; 2014 Jun 15; 55(6):1035-40. PubMed ID: 24752673
    [Abstract] [Full Text] [Related]

  • 52. Carbonic anhydrase IX expression in clear cell renal cell carcinoma: an immunohistochemical study comparing 2 antibodies.
    Al-Ahmadie HA, Alden D, Qin LX, Olgac S, Fine SW, Gopalan A, Russo P, Motzer RJ, Reuter VE, Tickoo SK.
    Am J Surg Pathol; 2008 Mar 15; 32(3):377-82. PubMed ID: 18300814
    [Abstract] [Full Text] [Related]

  • 53. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
    Svastová E, Hulíková A, Rafajová M, Zat'ovicová M, Gibadulinová A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastoreková S.
    FEBS Lett; 2004 Nov 19; 577(3):439-45. PubMed ID: 15556624
    [Abstract] [Full Text] [Related]

  • 54. Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.
    Petrul HM, Schatz CA, Kopitz CC, Adnane L, McCabe TJ, Trail P, Ha S, Chang YS, Voznesensky A, Ranges G, Tamburini PP.
    Mol Cancer Ther; 2012 Feb 19; 11(2):340-9. PubMed ID: 22147747
    [Abstract] [Full Text] [Related]

  • 55. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
    DePalatis LR, Johnson KA, Kaplan DA.
    Lab Invest; 1991 Jul 19; 65(1):111-20. PubMed ID: 2072661
    [Abstract] [Full Text] [Related]

  • 56. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
    Ditte P, Dequiedt F, Svastova E, Hulikova A, Ohradanova-Repic A, Zatovicova M, Csaderova L, Kopacek J, Supuran CT, Pastorekova S, Pastorek J.
    Cancer Res; 2011 Dec 15; 71(24):7558-67. PubMed ID: 22037869
    [Abstract] [Full Text] [Related]

  • 57. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ.
    J Clin Oncol; 2003 Feb 01; 21(3):473-82. PubMed ID: 12560438
    [Abstract] [Full Text] [Related]

  • 58. Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.
    Cheal SM, Punzalan B, Doran MG, Evans MJ, Osborne JR, Lewis JS, Zanzonico P, Larson SM.
    Eur J Nucl Med Mol Imaging; 2014 May 01; 41(5):985-94. PubMed ID: 24604591
    [Abstract] [Full Text] [Related]

  • 59. [Fusion expression of human renal cell carcinoma-associated antigen G250/MN/CA IX in prokaryotic expression system].
    Jiang YD, Zheng SB, Tan WL, Zhao SC, Ren F, Zhang B.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar 01; 27(3):307-9. PubMed ID: 17425979
    [Abstract] [Full Text] [Related]

  • 60. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16.
    Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I.
    Cancer Res; 1993 Jan 01; 53(1):94-100. PubMed ID: 8093231
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.